ClassID:

109979

C12N2710/22043 - CPC Classification

Classification description:

dsDNA viruses; Details; Polyomaviridae, e.g. polyoma, SV40, JC; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Recent Application in this class:
#1
20260085312
2026-03-26

COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID

#2
20250172561
2025-05-29

PROBE FOR UNIVERSAL DETECTION OF CIRCULATING TUMOR CELLS

#3
20250170272
2025-05-29

POLYOMAVIRAL GENE DELIVERY VECTOR PARTICLE COMPRISING A NUCLEIC ACID SEQUENCE ENCODING A PHOSPHATASE ACTIVITY-POSSESSING POLYPEPTIDE

#4
20250164490
2025-05-22

PROBE FOR UNIVERSAL DETECTION OF CIRCULATING TUMOR CELLS

#5
20250122260
2025-04-17

GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES

#6
20210102946
2021-04-08

Probe for universal detection of circulating tumor cells

#7
20190263883
2019-08-29

METHOD FOR AUGMENTING VISION IN PERSONS SUFFERING FROM PHOTORECEPTOR CELL DEGENERATION

#8
20190201549
2019-07-04

Drug delivery system based on JCV-VLP

#9
20190093125
2019-03-28

HIGH EFFICIENCY, HIGH THROUGHPUT GENERATION OF GENETICALLY MODIFIED NON-HUMAN MAMMALS BY MULTI-CYCLE ELECTROPORATION OF CAS9 PROTEIN

#10
20190062797
2019-02-28

Vectors and host cells comprising a modified SV40 promoter for protein expression

#11
20180296700
2018-10-18

NOVEL DRUG DELIVERY SYSTEM BASED ON JCV-VLP

#12
20170204469
2017-07-20

REPORTER VECTOR FOR EVALUATING CHARACTERISTICS OF SUBJECT CELL, ASSAY KIT, PROCEDURE AND DEVICE

#13
20160304902
2016-10-20

Expression vector for expressing heterogeneous gene

#14
20160265018
2016-09-15

Vectors and host cells comprising a modified SV40 promoter for protein expression

#15
20160022841
2016-01-28

Method for augmenting vision in persons suffering from photoreceptor cell degeneration

#16
20150368314
2015-12-24

Method of treating stomach or bowel-related disorders by administering glucagon-like-peptide-2 (GLP-2) analogues

#17
20140302076
2014-10-09

Immunogenic compositions and methods therefor

#18
20120289466
2012-11-15

Glucagon-like-peptide-2 (GLP-2) analogues

#19
20110152186
2011-06-23

Treatment of inflammatory bowel disease using glucagon-like-peptide-2 (GLP-2) analogues

#20
20110098222
2011-04-28

Glucagon-like-peptide-2 (GLP-2) analogues

#21
20100129913
2010-05-27

POLIOMA VECTOR EXPRESSING LONG DOUBLE-STRANDED RNAS

#22
20090305358
2009-12-10

DNA Vector Production System

#23
20070231308
2007-10-04

Glucagon-like-peptide-2 (GLP-2) analogues

#24
20070117752
2007-05-24

Methods of treating chemotherapy-induced diarrhea/mucositis using glucagon-like-peptide-2(GLP-2)analogues

#25
20050227317
2005-10-13

Mammalian expression system

#26
20050208022
2005-09-22

Method for augmenting vision in persons suffering from photoreceptor cell degeneration

#27
20050204422
2005-09-15

Cytoplasmic inhibition of gene expression

#28
20050118699
2005-06-02

Packaging complementation cell-line for sv-40 vectors

#29
19187712
2026-03-24

Composition for regulating production of interfering ribonucleic acid

#30
18891221
2025-11-25

Composition for regulating production of interfering ribonucleic acid

#31
18891208
2025-12-02

Composition for regulating production of interfering ribonucleic acid